Socio-demographic characteristics and sexual behavioral factors of patients with sexually transmittedFigure 2 Detailed picture of an umbilicated pustule with a necrotic centre and surrounded by an inflammatory plaque.

Metapneumovirus, Bocavirus, Respiratory syncytial virus, Adenovirus, and Enterovirus), but it was found to be negative. Lung involvement was not detected in thoracic tomography. Hydroxyzine (1 mg/kg/day), systemic methylprednisolone (1 mg/ kg/day), and phenyramine (1 mg/kg/day) treatments given for urticaria were thought to be resistant to treatment. Vitamin D (1,000 U/day) was added empirically to the patient's treatment. The patient's fever did not recur. The patient was discharged on the 5th day, after examinations for COVID-19 returned to normal and urticaria regressed. Overall, the therapy lasted 10 days. After discharge, hydroxyzine and phenyramine treatments were continued to the follow-up visit. On the 10th day, no pathology was observed in the physical examination and laboratory tests in the outpatient clinic control. Then, all medications were discontinued.elIn most pediatric cases, the diagnosis of COVID-19 may be delayed because of the cases presenting as an asymptomatic individual or with rare symptoms such as skin findings initially, or these patients may be missed without any diagnosis. [2][3][4][5] Our case presented with isolated symptoms such as urticarial rash that started suddenly and had fever of 38°C for 1 day, and COVID-19 was not considered by the pediatricians in which it was seen in the first place, and the patient was sent home with an antihistamine. This may pose a risk to ensuring the transmission control of SARS-CoV-2. Clinicians should be more careful in terms of the symptoms and positive physical examination findings of COVID-19 in the pediatric population, especially because of the start of face-to-face education in schools and the removal of restrictions on children.With this presentation, when acute urticaria and/or angioedema is encountered and rarely occurs in the patient, it is of great importance to bring the COVID-19 viral infection to mind and to narrow the contact circle and to treat the disease.

Patients with psoriasis have a higher prevalence of cardiovascular risk factors. This study evaluated cardiovascular screening practices and statin prescribing habits among dermatologists, rheumatologists and primary care physicians (PCPs) through an online questionnaire, which was distributed through the Spanish scientific societies of the above-mentioned specialties. A total of 299 physicians (103 dermatologists, 94 rheumatologists and 102 PCPs) responded to the questionnaire. Of these, 74.6% reported screening for smoking, 37.8% for hypertension, 80.3% for dyslipidaemia, and 79.6% for diabetes mellitus. Notably, only 28.4% performed global screening, defined as screening for smoking, hypertension, dyslipidaemia, and diabetes mellitus by the same physician, and 24.4% reported calculating 10-year cardiovascular disease (CVD) risk, probably reflecting a lack of comprehensive cardiovascular risk assessment in these patients. This study also identified unmet needs for awareness of cardiovascular comorbidities in psoriasis and corresponding screening and treatment recommendations among PCPs. Of PCPs, 61.2% reported not being aware of the association between psoriasis and CVD and/or not being aware of its screening recommendations, and 67.6% did not consider psoriasis as a risk-enhancing factor when deciding on statin prescription. Thirteen dermatologists (12.6%) and 35 rheumatologists (37.2%) reported prescribing statins. Among those who do not prescribe, 49.7% would be willing to start their prescription.

and, especially, the distribution of papules were otherwise similar, and both the COVID-19 infection and the absence of a pharmacological origin seem well documented.In conclusion, we report a case of a Gianotti-Crosti-like eruption in the setting of a COVID-19 infection. This is also a good example of the usefulness of teledermatology, a tool that is playing a major role in the pandemic, breaking down barriers to patient assessment derived from confinement and isolation measures. 9 More reports based on morphology and distribution of COVID-19 skin manifestations could be of great interest in this setting. Though we could not establish a definitive GCS diagnosis, we hope this report could modestly help clinicians to identify atypical presentations of the infection.